
Lupus erythematosus subacute-cutaneous L93.1
Lupus erythematosus, subacute-cutaneous. general view: multiple, solitary or confluent, small to large foci, sharply defined, partly homogeneous circular, partly also anular and gyrated, plaques with scales and crusts, trunk and extremities. 68-year-old female patient.

Purpura pigmentosa progressive L81.7
Purpura pigmentosa progressiva: aetiologically unexplained (medication?) pronounced clinical picture that has been changing for several months, with symmetrically distributed, disseminated, anular, non-expressable(!), non-itching, yellow-brown, spots (detailed picture).

Erythema dyschromicum perstans L81.02
Erythema dyschromicum perstans. 49-year-old male. Several months old with extensive gray-brown patches on the trunk. No itching. No drug history?

Acrocyanosis I73.81; R23.0;
Acrocyanosis: A flat, symptomless, blurredly limited, red-livid spot in the buttocks of a 52-year-old woman, which becomes much more prominent when exposed to cold.

Nevus anaemicus Q82.5
Naevus anaemicus: Approximately palm-sized, irregularly limited, white, smooth stain. No reddening after rubbing the stain. On glass spatula pressure the borders to the surrounding area disappear.

Purpura anularis teleangiectodes L81.7
Purpura anularis teleangiectodes: clinical picture that has existed for several months with anular, borderline reddish-brown (not push-off) spots and plaques; no itching

Diffuse cutaneous mastocytosis Q82.2
Mastocytosis diffuse of the skin: Disseminated large-area mastocytosis of the skin (type Ia); no systemic involvement detectable (detailed picture)

Becker's nevus D22.5
Becker-Naevus: chronically stationary, planar, splatter-like light brown pigmented, rough, sharply defined stain; no change in pigmentation in the last 20 months compared to the previous findings

Nevus anaemicus Q82.5

Drug effect adverse drug reactions (overview) L27.0

Amyloidosis macular cutaneous E85.4
Amyloidosis macular cutaneous: Large, long-standing, continuously spreading, blurred, symmetrical, light to medium brown spots and plaques; histological evidence of the amyloid.

Drug exanthema maculo-papular L27.0
Drug exanthema after ingestion of a cephalosporin. 4 days after continuous intake of the antibiotic, sudden (overnight) development of this moderately itchy, maculo-papular exanthema. Noticeable is the emphasis on UV-exposed areas. However, UV exposure of these skin areas was (demonstrably) months ago.

Phototoxic dermatitis L56.0

Vitiligo (overview) L80
Vitiligo: generalized vitiligo in a young Ethiopian. sharply defined, almost symmetrically arranged depigmentations, mostly of large and small area. on close inspection, further, multiple, less sharply marked incompetently depigmented spots (grey-brown stains) can be found.

Drug exanthema maculo-papular L27.0

Ecchymosis syndrome, painful R23.8

Atrophodermia idiopathica et progressiva L90.3
Atrophodermia idiopathica et progressiva: extensive, poorly indurated circumscribed circumscribed scleroderma (Morphea).

Atrophodermia idiopathica et progressiva L90.3
Atrophodermia idiopathica et progressiva: Large, erythematous-livid to brown, confluent, discreetly indurated, smooth, blurred spots and plaques (acquired mosaic dermatosis, chessboard-like pattern).